Los Angeles Capital Management’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-11,138
| Closed | -$1.43M | – | 1374 |
|
|
2025
Q2 | $1.43M | Hold |
11,138
| – | – | 0.01% | 543 |
|
|
2025
Q1 | $986K | Sell |
11,138
-41
| -0.4% | -$4K | ﹤0.01% | 569 |
|
|
2024
Q4 | $975K | Hold |
11,179
| – | – | ﹤0.01% | 630 |
|
|
2024
Q3 | $1.03M | Sell |
11,179
-3,260
| -23% | -$324K | ﹤0.01% | 643 |
|
|
2024
Q2 | $1.56M | Sell |
14,439
-64
| -0.4% | -$6.41K | 0.01% | 511 |
|
|
2024
Q1 | $1.38M | Buy |
14,503
+10
| +0.1% | +$858 | ﹤0.01% | 589 |
|
|
2023
Q4 | $1.34M | Hold |
14,493
| – | – | 0.01% | 577 |
|
|
2023
Q3 | $728K | Buy |
14,493
+355
| +3% | +$19K | ﹤0.01% | 733 |
|
|
2023
Q2 | $894K | Buy |
14,138
+8,077
| +133% | +$439K | ﹤0.01% | 677 |
|
|
2023
Q1 | $273K | Buy |
6,061
+899
| +17% | +$40.5K | ﹤0.01% | 1041 |
|
|
2022
Q4 | $226K | Sell |
5,162
-600
| -10% | -$28.8K | ﹤0.01% | 1118 |
|
|
2022
Q3 | $380K | Buy |
+5,762
| New | +$370K | ﹤0.01% | 1002 |
|
|
2022
Q1 | – | Sell |
-15,732
| Closed | -$1.69M | – | 1413 |
|
|
2021
Q4 | $1.69M | Sell |
15,732
-174
| -1% | -$18.2K | 0.01% | 559 |
|
|
2021
Q3 | $1.64M | Hold |
15,906
| – | – | 0.01% | 581 |
|
|
2021
Q2 | $1.4M | Sell |
15,906
-3,490
| -18% | -$320K | 0.01% | 715 |
|
|
2021
Q1 | $1.89M | Sell |
19,396
-13,555
| -41% | -$1.35M | 0.01% | 643 |
|
|
2020
Q4 | $3.69M | Sell |
32,951
-1,540
| -4% | -$162K | 0.02% | 471 |
|
|
2020
Q3 | $3.2M | Sell |
34,491
-6,336
| -16% | -$488K | 0.01% | 435 |
|
|
2020
Q2 | $3.19M | Buy |
40,827
+17,324
| +74% | +$1.17M | 0.02% | 497 |
|
|
2020
Q1 | $1.37M | Buy |
23,503
+6,448
| +38% | +$415K | 0.01% | 635 |
|
|
2019
Q4 | $1.37M | Sell |
17,055
-2,460
| -13% | -$184K | 0.01% | 743 |
|
|
2019
Q3 | $1.43M | Sell |
19,515
-1,790
| -8% | -$155K | 0.01% | 712 |
|
|
2019
Q2 | $2.01M | Buy |
21,305
+3,415
| +19% | +$282K | 0.01% | 642 |
|
|
2019
Q1 | $1.43M | Buy |
17,890
+1,615
| +10% | +$119K | 0.01% | 741 |
|
|
2018
Q4 | $877K | Sell |
16,275
-5,915
| -27% | -$360K | 0.01% | 782 |
|
|
2018
Q3 | $1.73M | Sell |
22,190
-4,050
| -15% | -$281K | 0.01% | 702 |
|
|
2018
Q2 | $1.67M | Buy |
26,240
+20,230
| +337% | +$1.61M | 0.01% | 745 |
|
|
2018
Q1 | $551K | Buy |
+6,010
| New | +$518K | ﹤0.01% | 1004 |
|
Other funds holding BPMC
IA
HNB
Los Angeles Capital Management's BPMC Position: Q3 2025 in Review
Los Angeles Capital Management sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 11,138 shares — an estimated $1.43M sold.
Los Angeles Capital Management first reported a position in BPMC in Q1 2018 and held it in 28 quarters. The position peaked at $3.69M in Q4 2020. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Los Angeles Capital Management reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Los Angeles Capital Management sold 11,138 Blueprint Medicines shares in Q3 2025, an estimated $1.43M.
- Los Angeles Capital Management first reported a position in Blueprint Medicines in Q1 2018 and held it in 28 quarters.
- Los Angeles Capital Management's Blueprint Medicines position peaked at $3.69M in Q4 2020.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Los Angeles Capital Management's 13F filing for Q3 2025, filed 20 Oct 2025.